Patent · US Active

PSMA-targeting compounds and uses thereof

US9056841B2 · kind B2 · utility

44Cited by
0References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 19, 2010
Grant dateJun 16, 2015
Priority date
Expiry dateApr 19, 2031

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/342
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Prostate-specific membrane antigen (PSMA) targeting compounds are described. Uses of the compounds for imaging, therapy, cell sorting, and tumor mapping are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.